Axelar AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Axelar AB - overview
Established
2003
Location
-, -, Sweden
Primary Industry
Biotechnology
About
Axelar AB is a Swedish technology firm specializing in advanced IT solutions for research and medical technology sectors, focusing on blockchain applications and software for medical devices. Founded in 2003 in Sweden, Axelar AB provides IT solutions primarily for the medical technology sector. The company has undergone strategic pivots to refine its offerings, focusing on blockchain technology for secure data management in healthcare. The company was formed with the intent of enhancing operational efficiencies in the healthcare sector and has a significant presence in Europe and North America.
The founder's prior entrepreneurial experience is not detailed in the available information. Axelar has completed one funding deal, which occurred on June 12, 2008, receiving investment from Karolinska Development and Östersjöstiftelsen. Axelar AB specializes in providing advanced IT solutions tailored for research and medical technology sectors. Its core offerings include blockchain technology and IT software designed for medical devices, enhancing operational efficiency in healthcare settings.
The blockchain technology ensures secure data management and interoperability among various healthcare systems, while the IT software solutions facilitate the development and deployment of medical devices, catering mainly to medical device manufacturers and research institutions across Europe and North America. The company serves diverse clients, including hospitals and academic research organizations, addressing the rigorous demands of the medical field. In 2019, Axelar AB reported no revenue, and its EBITDA was USD -444,432. 30.
The company primarily operates on a B2B revenue model, partnering with medical technology developers and research institutions through service contracts and software licensing agreements. The revenue generation strategy focuses on proprietary IT software and blockchain solutions, with pricing structures tailored to each client's specific needs, ensuring compliance with evolving healthcare regulations. Axelar AB plans to expand its product offerings, focusing on the development of new software solutions and blockchain applications tailored for the healthcare industry. The company aims to explore new geographic markets in Europe and North America, specifically targeting regions with emerging medical technology sectors by 2025.
The funding from the June 2008 deal will support these initiatives, enabling the company to enhance product development and market penetration strategies.
Current Investors
KDventures, Östersjöstiftelsen
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.axelar.se
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Axelar AB - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 168,487 | 344,784 | 12,324 | 39,991 | 1 | - | - | - |
| % Revenue Growth (YoY) | - | - | 104.6% | (96.4%) | 224.5% | (100.0%) | - | - | - |
| EBITDA (USD) | (29,203,261) | (41,403,419) | (23,021,369) | (14,585,215) | (5,954,023) | (5,127,375) | - | - | - |
| Operating Income (USD) | (29,633,233) | (42,305,896) | (24,068,713) | (15,650,824) | (7,019,623) | (5,944,410) | - | - | - |
| Operating Margin | - | (25109.3%) | (6980.8%) | (126994.7%) | (17553.0%) | (594441000.0%) | - | - | - |
| % EBITDA Margin | - | (24573.7%) | (6677.0%) | (118348.1%) | (14888.4%) | (512737500.0%) | - | - | - |
| NET Income (USD) | (29,200,004) | (41,900,838) | (23,731,910) | (15,388,210) | (7,033,832) | (5,828,462) | - | - | - |
| % Net Margin | - | (24868.9%) | (6883.1%) | (124863.8%) | (17588.5%) | (582846200.0%) | - | - | - |
Axelar AB - employee data
Axelar AB - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Board member | BM | ||||||
| Chairman of the Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.